Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 5,7-dihydroxy-flavone
2. 5,7-dihydroxyflavone
3. Chrysine
1. 480-40-0
2. 5,7-dihydroxyflavone
3. 5,7-dihydroxy-2-phenyl-4h-chromen-4-one
4. Chrysine
5. 5,7-dihydroxy-2-phenylchromen-4-one
6. Crysin
7. 4h-1-benzopyran-4-one, 5,7-dihydroxy-2-phenyl-
8. Nsc-407436
9. Chrysinic Acid
10. Flavone, 5,7-dihydroxy-
11. Nsc 407436
12. 5,7-dihydroxy-2-phenyl-4h-1-benzopyran-4-one
13. 5,7-dihydroxy-2-phenyl-chromen-4-one
14. Mfcd00006834
15. Nsc407436
16. Chembl117
17. 3cn01f5zj5
18. Chebi:75095
19. 5,7-dihydroxy-2-phenyl-4h-benzo(b)pyran-4-one
20. 5,7-dihydroxy-2-phenyl-4h-benzo[b]pyran-4-one
21. Cas-480-40-0
22. Smr000112318
23. Sr-01000765660
24. Einecs 207-549-7
25. Brn 0233276
26. Unii-3cn01f5zj5
27. 3ebo
28. 4des
29. 57d
30. Chrysin,(s)
31. 5,7-dioh-flavone
32. Flavone,7-dihydroxy-
33. Chrysin, 97%
34. Ois 3
35. Spectrum_000245
36. 5, 7-dihydroxyflavone
37. Chrysin [inci]
38. Chrysin [mi]
39. Prestwick0_000889
40. Prestwick1_000889
41. Prestwick2_000889
42. Prestwick3_000889
43. Spectrum2_000753
44. Spectrum3_001399
45. Spectrum4_000780
46. Spectrum5_001503
47. Dsstox_cid_2396
48. Chrysin, Analytical Standard
49. Dsstox_rid_76571
50. Dsstox_gsid_22396
51. Oprea1_045160
52. Schembl44474
53. Bspbio_000678
54. Bspbio_002514
55. Bspbio_003018
56. Kbiogr_001200
57. Kbioss_000725
58. 5-18-04-00076 (beilstein Handbook Reference)
59. Mls000697728
60. Mls001074879
61. Mls006011841
62. Bidd:er0484
63. Divk1c_000614
64. Spectrum1500709
65. Spectrum1505144
66. Spbio_000766
67. Spbio_002897
68. Bdbm7461
69. Bpbio1_000746
70. Gtpl8789
71. Megxp0_001416
72. Dtxsid1022396
73. Acon1_000087
74. Cid_5281607
75. Hms501o16
76. Kbio1_000614
77. Kbio2_000725
78. Kbio2_003293
79. Kbio2_005861
80. Kbio3_002238
81. Ninds_000614
82. Hms1570b20
83. Hms1921e20
84. Hms2097b20
85. Hms2268i23
86. Hms3468n08
87. Hms3655l20
88. Albb-015581
89. Bcp22863
90. Zinc3872070
91. Tox21_302335
92. Bbl010449
93. Ccg-40148
94. Lmpk12110189
95. Nsc818102
96. S2281
97. Stk801609
98. Akos000275936
99. Bcp9000172
100. Cs-7531
101. Db15581
102. Gs-0927
103. Nsc-818102
104. Sdccgmls-0066586.p001
105. Idi1_000614
106. Smp1_000070
107. Ncgc00016456-01
108. Ncgc00016456-02
109. Ncgc00016456-03
110. Ncgc00016456-04
111. Ncgc00016456-05
112. Ncgc00016456-06
113. Ncgc00016456-07
114. Ncgc00016456-08
115. Ncgc00016456-09
116. Ncgc00016456-10
117. Ncgc00016456-12
118. Ncgc00094842-01
119. Ncgc00094842-02
120. Ncgc00094842-03
121. Ncgc00094842-04
122. Ncgc00094842-05
123. Ncgc00168807-01
124. Ncgc00168807-02
125. Ncgc00168807-03
126. Ncgc00168807-04
127. Ncgc00255307-01
128. Ac-10052
129. Hy-14589
130. Nci60_003886
131. Sy050125
132. Ab00513947
133. C1652
134. Ft-0619846
135. Ft-0686390
136. N1336
137. Sw197197-2
138. 5,7-dihydroxy-2-phenyl-4h-chromen-4-one #
139. 4h-1-benzopyran-4-one,7-dihydroxy-2-phenyl-
140. 80c400
141. C-5980
142. S00112
143. Chrysin 1000 Microg/ml In Acetonitrile:methanol
144. A827426
145. Q973741
146. Sr-01000765660-3
147. Sr-01000765660-4
148. 34b3b4ad-eedd-4943-a1c6-8857d2faa8e0
149. 5,7-dihydroxy-2-phenyl-4h-1-benzopyran-4-one, 9ci
150. Brd-k22861715-001-07-5
151. Brd-k22861715-001-12-5
| Molecular Weight | 254.24 g/mol |
|---|---|
| Molecular Formula | C15H10O4 |
| XLogP3 | 2.1 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 1 |
| Exact Mass | 254.05790880 g/mol |
| Monoisotopic Mass | 254.05790880 g/mol |
| Topological Polar Surface Area | 66.8 Ų |
| Heavy Atom Count | 19 |
| Formal Charge | 0 |
| Complexity | 384 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Chrysin has known human metabolites that include (2S,3S,4S,5R)-3,4,5-trihydroxy-6-(5-hydroxy-4-oxo-2-phenylchromen-7-yl)oxyoxane-2-carboxylic acid.
S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560
ABOUT THIS PAGE
92
PharmaCompass offers a list of Chrysin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Chrysin manufacturer or Chrysin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Chrysin manufacturer or Chrysin supplier.
PharmaCompass also assists you with knowing the Chrysin API Price utilized in the formulation of products. Chrysin API Price is not always fixed or binding as the Chrysin Price is obtained through a variety of data sources. The Chrysin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Crysin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Crysin, including repackagers and relabelers. The FDA regulates Crysin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Crysin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Crysin supplier is an individual or a company that provides Crysin active pharmaceutical ingredient (API) or Crysin finished formulations upon request. The Crysin suppliers may include Crysin API manufacturers, exporters, distributors and traders.
Crysin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Crysin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Crysin GMP manufacturer or Crysin GMP API supplier for your needs.
A Crysin CoA (Certificate of Analysis) is a formal document that attests to Crysin's compliance with Crysin specifications and serves as a tool for batch-level quality control.
Crysin CoA mostly includes findings from lab analyses of a specific batch. For each Crysin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Crysin may be tested according to a variety of international standards, such as European Pharmacopoeia (Crysin EP), Crysin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Crysin USP).
